Fujifilm Set To Begin 2013 Trials For Leukemia Drug, 2014 For Cancer Drug
This article was originally published in PharmAsia News
Fujifilm is on track to begin Japan clinical trials next year for an oral drug to treat a leukemia precursor next year and a drug against both ovarian and pancreatic cancer in the U.S. the following year.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.